Rare diseases
Investigational molecules
Locations
Study of QEL-001 (CAR T regulatory cell therapy) to prevent liver transplant rejection in patients with HLA-A2 positive donor organ
BelgiumStudy on the Effect of Allopurinol and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy
AustriaStudy on the Long-Term Safety of Glepaglutide for Adults with Short Bowel Syndrome
BelgiumStudy on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery
FranceStudy on Bezafibrate for Patients with Primary Sclerosing Cholangitis and Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy
FranceStudy Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma
BelgiumStudy of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson's Disease
DenmarkStudy on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid
BelgiumStudy on Amantadine and Transcranial Magnetic Stimulation for Reducing Fatigue in Multiple Sclerosis Patients
SpainStudy of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)
FranceStudy on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors
The NetherlandsStudy on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
